Home › Encyclopedia › Sermorelin: Research Status and Trial Data
Research / Unapproved

Sermorelin: Research Status and Trial Data

Molecular formulaC149H246N44O42S
Molecular weight3357.9 g/mol
Registered trials42
PubChem CID16132413

What Sermorelin Is

Sermorelin is a peptide studied in clinical research settings. It does not currently carry an approved drug label, so there is no FDA-sanctioned indication, dosing guidance, or official prescribing information to reference. Its chemical identity is catalogued under PubChem CID 16132413.

Trial Footprint

Sermorelin has been studied across 42 registered clinical trials. Sampled studies include a Phase 1 trial examining growth hormone releasing hormone and cognitive function in individuals with mild cognitive impairment, which has been completed. A separate Phase 3 trial compared a growth hormone releasing hormone and arginine test for diagnosing adult growth hormone deficiency, also completed. Another sampled study, a Phase 1 trial on estradiol receptor blockade in older men and women, has likewise reached completion. These entries describe the scope of registered research activity and do not establish safety or effectiveness for any use.

FAQ

Is sermorelin FDA approved?
No approved label is on file for sermorelin in the data reviewed here. It is studied as a research compound rather than marketed as an approved drug.
What has sermorelin been studied for?
Registered trials sampled here include research on growth hormone releasing hormone in the context of cognitive function and in diagnostic testing for adult growth hormone deficiency. A total of 42 trials have been registered involving this compound.
How many clinical trials involve sermorelin?
There are 42 registered clinical trials associated with sermorelin. These range across different research questions and trial designs, including completed Phase 1 and Phase 3 studies.
What is the chemical identity of sermorelin?
Sermorelin is catalogued in PubChem under CID 16132413. This identifier allows researchers to reference its chemical structure and properties consistently across databases.
Are there known side effects reported for sermorelin?
No adverse event report data was available in the dataset reviewed for this monograph. This does not confirm the absence of side effects, only that no report data was provided here.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: ClinicalTrials.gov PubChem

Updated 2026-11-07